121 related articles for article (PubMed ID: 24712844)
1. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
Zhang Z; Guo Y
Neoplasma; 2014 Apr; ():. PubMed ID: 24712844
[TBL] [Abstract][Full Text] [Related]
2. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
Zhang Z; Guo Y
Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of TBX2 expression in non-small cell lung cancer.
Hu B; Mu HP; Zhang YQ; Su CY; Song JT; Meng C; Liu DX
J Mol Histol; 2014 Aug; 45(4):421-6. PubMed ID: 24531749
[TBL] [Abstract][Full Text] [Related]
4. High Sam68 expression predicts poor prognosis in non-small cell lung cancer.
Zhang Z; Xu Y; Sun N; Zhang M; Xie J; Jiang Z
Clin Transl Oncol; 2014 Oct; 16(10):886-91. PubMed ID: 24522888
[TBL] [Abstract][Full Text] [Related]
5. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
Yang H; Gao XY; Li P; Jiang TS
Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
[TBL] [Abstract][Full Text] [Related]
6. Elevated expression of Cripto-1 correlates with poor prognosis in non-small cell lung cancer.
Xu CH; Sheng ZH; Hu HD; Hao KK; Wang QB; Yu LK
Tumour Biol; 2014 Sep; 35(9):8673-8. PubMed ID: 24870591
[TBL] [Abstract][Full Text] [Related]
7. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
[TBL] [Abstract][Full Text] [Related]
8. T-box 2 expression predicts poor prognosis in gastric cancer.
Yu H; Liu BO; Liu A; Li K; Zhao H
Oncol Lett; 2015 Sep; 10(3):1689-1693. PubMed ID: 26622733
[TBL] [Abstract][Full Text] [Related]
9. Cell cycle-related and expression-elevated protein in tumor overexpression is associated with proliferation behaviors and poor prognosis in non-small-cell lung cancer.
Li W; Zheng G; Xia J; Yang G; Sun J; Wang X; Wen M; Sun Y; Zhang Z; Jin F
Cancer Sci; 2018 Apr; 109(4):1012-1023. PubMed ID: 29397041
[TBL] [Abstract][Full Text] [Related]
10. The expression level and prognostic value of HIPK3 among non-small-cell lung cancer patients in China.
Liu Y; Qian L; Yang J; Huang H; Feng J; Li X; Bian T; Ke H; Liu J; Zhang J
Onco Targets Ther; 2018; 11():7459-7469. PubMed ID: 30498360
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
12. Association of TBX2 and P21 expression with clinicopathological features and survival of laryngeal squamous cell carcinoma.
Huang Y; Li Z; Zhong Q; Li G; Zhang Y; Huang Z
Int J Clin Exp Med; 2014; 7(12):5394-402. PubMed ID: 25664048
[TBL] [Abstract][Full Text] [Related]
13. Sestrin2 expression is a favorable prognostic factor in patients with non-small cell lung cancer.
Chen KB; Xuan Y; Shi WJ; Chi F; Xing R; Zeng YC
Am J Transl Res; 2016; 8(4):1903-9. PubMed ID: 27186314
[TBL] [Abstract][Full Text] [Related]
14. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS
Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781
[TBL] [Abstract][Full Text] [Related]
15. miR-1290 is a potential prognostic biomarker in non-small cell lung cancer.
Mo D; Gu B; Gong X; Wu L; Wang H; Jiang Y; Zhang B; Zhang M; Zhang Y; Xu J; Pan S
J Thorac Dis; 2015 Sep; 7(9):1570-9. PubMed ID: 26543604
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of HMGB3 expression in patients with non-small cell lung cancer.
Song N; Liu B; Wu JL; Zhang RF; Duan L; He WS; Zhang CM
Tumour Biol; 2013 Oct; 34(5):2599-603. PubMed ID: 23609034
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of long noncoding RNA uc.338 predicts poor survival in non-small cell lung cancer.
Tian Y; Feng Y
Cancer Biomark; 2018; 22(4):781-785. PubMed ID: 29843223
[TBL] [Abstract][Full Text] [Related]
18. Tazarotene-induced gene 2 is associated with poor survival in non-small cell lung cancer.
Cai Q; Huang Z; Qi L; Wang T; Shen Y; Huang J
Oncol Lett; 2016 Oct; 12(4):2680-2685. PubMed ID: 27698842
[TBL] [Abstract][Full Text] [Related]
19. Low claudin-6 expression correlates with poor prognosis in patients with non-small cell lung cancer.
Wang Q; Zhang Y; Zhang T; Han ZG; Shan L
Onco Targets Ther; 2015; 8():1971-7. PubMed ID: 26261421
[TBL] [Abstract][Full Text] [Related]
20. Overexpressed C14orf166 associates with disease progression and poor prognosis in non-small-cell lung cancer.
Zhou YW; Li R; Duan CJ; Gao Y; Cheng YD; Zhang CF
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30126850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
